Panacea
AI-Native FDA Regulatory Services
What they do
Biotech and medical device companies face slow, complex, and expensive FDA regulatory processes that delay approval.
Panacea combines experienced ex-FDA regulatory consultants with an AI platform to deliver fixed-price, milestone-based FDA regulatory services across major submission pathways.
Biotech and medical device companies seeking FDA clearance or approval.
Founders
ex-GTM (Partnerships Lead) @ Anterior - backed by Sequoia, NEA and Microsoft AI's CEO. MD, Imperial College Medical School, Imperial College Business School.
Ex-AI Platform Engineer @ Anterior - backed by Sequoia, NEA and Microsoft AI's CEO. MS in AI from University of Illinois, Chicago. Ex-Software Engineer @ Bloomberg on the NoSQL Infrastructure Team. Co-founded & bootstrapped Baqi, scaled to $5M+ in transactions with 20+ enterprise partnerships.
Company timeline
- Founded2026
- YC batchSpring 2026
- StatusActive
- Team size2 people
- LocationSan Francisco, CA, USA
Similar startups
